TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06610721 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study NCT05598411 — Predictive Biomarker (PRD): CST1 mRNA
Genes: CST1
Study NCT05011357 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06055348 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT05768230 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT05768230 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT00455039 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00455039 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05965947 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05007080 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04834505 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study NCT05184712 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05184712 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05893368 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05365360 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT05179382 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05940116 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05940116 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05541146 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT06660420 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study NCT04700332 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04677816 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT05655663 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT05980481 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05980481 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05277220 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06062394 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06578637 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06209879 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05809752 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05809752 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT06606301 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06610227 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MHC class I polypeptide-related sequence A
Genes: MICA; PERB11.1
Study NCT06728189 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT06219746 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05055505 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04789096 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05638594 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05638594 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05139602 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06533007 — Predictive Biomarker (PRD): PDE3B mRNA
Genes: PDE3B
Study NCT05833958 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04470518 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05204927 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06073613 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05564780 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06089265 — Predictive Biomarker (PRD): KHK mRNA
Genes: KHK
Study NCT04733118 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04733118 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06648200 — Predictive Biomarker (PRD): BTLA mRNA
Genes: BTLA
Study NCT05939934 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04692324 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05161728 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05161728 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT06019208 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00002323 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05687357 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04465643 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT06070181 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05618548 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05918718 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06723249 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06496490 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05802225 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06377046 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06219733 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study NCT06414837 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT06039449 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05891197 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT06439173 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06522074 — Predictive Biomarker (PRD): GHR mRNA
Genes: GHR
Study NCT06406179 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06509126 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT06509126 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05783206 — Predictive Biomarker (PRD): MLXIP mRNA
Genes: MLXIP; BHLHE36; KIAA0867; MIR; MONDOA
Study NCT06350032 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT06280079 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05694949 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06609785 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT06610123 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT05749484 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT04874285 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05426486 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04955340 — Predictive Biomarker (PRD): HDAC6 mRNA
Genes: HDAC6; KIAA0901; JM21
Study NCT04596189 — Monitoring Biomarker (MOI): IL4 mRNA
Genes: IL4
Study NCT04596189 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT04925687 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05747157 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05845138 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06152185 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05625321 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05297162 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05201118 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06335225 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT04771416 — Predictive Biomarker (PRD): GALC mRNA
Genes: GALC
Study NCT05510089 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05510089 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06461702 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT06461702 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05197725 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04679480 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05949294 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05908045 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05588466 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05571371 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study NCT04781374 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05966597 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05134831 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05595369 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06220929 — Predictive Biomarker (PRD): GSDMD mRNA
Genes: GSDMD; DFNA5L; GSDMDC1; FKSG10
Study NCT06220929 — Predictive Biomarker (PRD): GSDME mRNA
Genes: GSDME; DFNA5; ICERE1
Study NCT06091826 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT06046950 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05529147 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05295810 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05311436 — Predictive Biomarker (PRD): EED mRNA
Genes: EED
Study NCT05874557 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05874557 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT06562192 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06562192 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05617014 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06392009 — Predictive Biomarker (PRD): RRAD mRNA
Genes: RRAD; RAD
Study NCT05902156 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06019793 — Predictive Biomarker (PRD): PAG1 mRNA
Genes: PAG1; CBP; PAG
Study NCT05169567 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05169567 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05169567 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05169567 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05169567 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05933174 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05653388 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06665165 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT00002009 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05812157 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT05357430 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05399420 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06259552 — Predictive Biomarker (PRD): LILRB2 mRNA
Genes: LILRB2; ILT4; LIR2; MIR10
Study NCT05748223 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06665646 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT06682455 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06683430 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06683430 — Surrogate Endpoint (SUR): Serum potassium
Study NCT06589960 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04858828 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT04858828 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06610825 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04895722 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT06055452 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06136949 — Predictive Biomarker (PRD); Safety Biomarker (SAF): STAR mRNA
Genes: STAR; STARD1
Study NCT06445673 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT06445673 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT06355310 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04183413 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06391008 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05358821 — Predictive Biomarker (PRD): SAGE1 mRNA
Genes: SAGE1; SAGE
Study NCT05358821 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT04021550 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05624476 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06479070 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06373523 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04253080 — Predictive Biomarker (PRD): IL4I1 mRNA
Genes: IL4I1; FIG1; UNQ636/PRO1265
Study NCT04253080 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT04253080 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04853316 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05661786 — Monitoring Biomarker (MOI): HBV DNA
Study NCT06718413 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06723652 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06723236 — Predictive Biomarker (PRD): ADAM9 mRNA
Genes: ADAM9; KIAA0021; MCMP; MDC9; MLTNG
Study NCT05644145 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06525987 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06375044 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT06375044 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05722327 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06427564 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03947190 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study NCT06646354 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06646354 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05661812 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT04982224 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT04079621 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT04764448 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT05388370 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT05190146 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT04976283 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05104281 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05104281 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03941496 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study NCT04792073 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT05402332 — Predictive Biomarker (PRD): PGM1 mRNA
Genes: PGM1
Study NCT05392062 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05885724 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT05885724 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05885724 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05395091 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05666804 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05666804 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05288491 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT01645293 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT06162650 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06462508 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05939531 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05734898 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT05671822 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05800223 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05256654 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05256654 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06523569 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05209776 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05202353 — Predictive Biomarker (PRD): GCG mRNA
Genes: GCG
Study NCT05442996 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04969029 — Predictive Biomarker (PRD): POLE mRNA
Genes: POLE; POLE1
Study NCT04969029 — Predictive Biomarker (PRD): POLD1 mRNA
Genes: POLD1; POLD
Study NCT06580002 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06580002 — Safety Biomarker (SAF): BDNF
Study NCT05249868 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05032066 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06067061 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04133506 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT05946811 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05983991 — Predictive Biomarker (PRD): GATA2 mRNA
Genes: GATA2
Study NCT05790837 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05790837 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05353322 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05787808 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00000818 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06444412 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05803031 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04706962 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04706962 — Predictive Biomarker (PRD): SORT1 mRNA
Genes: SORT1
Study NCT00000905 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05415943 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05866068 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04639271 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05797935 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05713240 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06363396 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT06363396 — Predictive Biomarker (PRD): SV2A mRNA
Genes: SV2A; KIAA0736; PSEC0174
Study NCT06134570 — Predictive Biomarker (PRD): ALDH1A1 mRNA
Genes: ALDH1A1; ALDC; ALDH1; PUMB1
Study NCT05776407 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04689373 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05094635 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05055557 — Predictive Biomarker (PRD): HAS2 mRNA
Genes: HAS2
Study NCT05055557 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05327556 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06133335 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06044857 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05477615 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05491200 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study NCT05472038 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05835765 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study NCT06124781 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study NCT04396366 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05392608 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05392608 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05392608 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05392608 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05418088 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05418088 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT05579418 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05579418 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03957161 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05832073 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05435768 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06264531 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06264531 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00475527 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT05768100 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06172374 — Predictive Biomarker (PRD): DNAI1 mRNA
Genes: DNAI1
Study NCT04714827 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04714827 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05962619 — Safety Biomarker (SAF): Hyaluronic acid